Psoriasis Trials in St. Louis, United States
Conditions / Psoriasis / St. Louis, United States
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
57 total trials for this combination
Showing top 10 of 57 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT01163253 | A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis | TERMINATED | PHASE3 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT00261976 | A Long-term Safety Study of Infliximab (Remicade) | COMPLETED | — |
| NCT00195676 | Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis | COMPLETED | PHASE3 |
| NCT04036435 | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03816345 | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO | RECRUITING | — |
| NCT00454701 | Assessment and Tracking of Long-term Alefacept Safety | TERMINATED | — |
| NCT00508547 | Psoriasis Longitudinal Assessment and Registry | ACTIVE_NOT_RECRUITING | — |